Histologically, ALK+ DLBCL shows a sinusoidal growth pattern, plasmacytic and T-cell lineage markers with CD30 and single light-chain cytoplasmic immunoglobulin A (IgA) expression, and a lack of CD20 and CD79α markers. This evidence concerns the gene CD79A and diffuse large B-cell lymphoma.